Long-term reversal of diabetes by the injection of immunoprotected islets

scientific article

Long-term reversal of diabetes by the injection of immunoprotected islets is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1993PNAS...90.5843S
P356DOI10.1073/PNAS.90.12.5843
P932PMC publication ID46819
P698PubMed publication ID8516335
P5875ResearchGate publication ID14683655

P50authorTerje EspevikQ15734296
P2093author name stringYao Z
Nelson R
Zheng T
Feldman E
Heintz R
Yao Q
Soon-Shiong P
Merideth N
Skjak-Braek G
P2860cites workMicroencapsulated islets as bioartificial endocrine pancreasQ34269177
Inducible interleukin-1 gene expression in human vascular smooth muscle cellsQ34548807
Induction of cytokine production from human monocytes stimulated with alginateQ34968426
An immunologic basis for the fibrotic reaction to implanted microcapsules.Q35012452
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activitiesQ39507424
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetesQ41293878
Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated isletsQ44410668
Human C-peptide response in xenotransplanted diabetic Lewis ratsQ46319388
Glucose-insulin kinetics of the extravascular bioartificial pancreas. A study using microencapsulated rat isletsQ51603962
Effects of Pancreatic Transplantation on Diabetic NeuropathyQ60681694
Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary reportQ68054209
The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod miceQ68083681
Microencapsulated hepatocytes as a bioartificial liverQ68915313
Immunoisolation of pancreatic B cells by microencapsulation. An in vitro studyQ69972593
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)5843-5847
P577publication date1993-06-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleLong-term reversal of diabetes by the injection of immunoprotected islets
P478volume90

Reverse relations

cites work (P2860)
Q288291753D Cell Culture in Alginate Hydrogels
Q39051114Advances in islet encapsulation technologies
Q46521466Alginate assessment by NMR microscopy
Q40885387Alginate based new materials
Q34420908An encapsulation system for the immunoisolation of pancreatic islets
Q73483180Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse, and human pancreatic islets
Q40587998Association between macrophage activation and function of micro-encapsulated rat islets
Q41296005Biocompatibility issues of implantable drug delivery systems
Q38130163Bioengineered sites for islet cell transplantation
Q38294476Biomaterials in tissue engineering
Q33796406Carbohydrates in transplantation
Q36750715Cloning and expression of an Azotobacter vinelandii mannuronan C-5-epimerase gene
Q39547101Cloning and expression of three new Aazotobacter vinelandii genes closely related to a previously described gene family encoding mannuronan C-5-epimerases.
Q30439009Core-shell hydrogel microcapsules for improved islets encapsulation.
Q74444960Culture of chondrocytes in alginate gel: variations in conditions of gelation influence the structure of the alginate gel, and the arrangement and morphology of proliferating chondrocytes
Q38123626Current status of islet encapsulation
Q47217806Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes
Q44236948Deterioration of polyamino acid-coated alginate microcapsules in vivo
Q34187908Diabetes mellitus and closed-loop insulin delivery
Q73118229Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells
Q87411475Encapsulate this: the do's and don'ts
Q45887969Encapsulated cell technology
Q26866524Encapsulated islet transplantation: strategies and clinical trials
Q37106938Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: in vitro and in vivo function
Q44029525Encapsulation of insulin in chitosan-coated alginate beads: oral therapeutic peptide delivery
Q34713899Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug
Q48229772Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin
Q44632895Factors Influencing Insulin Secretion from Encapsulated Islets
Q34340699Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes.
Q34003144Immunocompatibility and biocompatibility of cell delivery systems
Q40427311Implantable Biohybrid Artificial Organs
Q40631516Improving cell encapsulation through size control
Q84090337Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells
Q52082665Inhomogeneous alginate gel spheres: an assessment of the polymer gradients by synchrotron radiation-induced X-ray emission, magnetic resonance microimaging, and mathematical modeling.
Q29395650Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation
Q40721665Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers
Q74414564Is it possible to use the standard alginate-PLL procedure for production of small capsules?
Q34972386Islet and stem cell encapsulation for clinical transplantation
Q34452096Islet cell transplantation for the treatment of diabetes mellitus
Q45712216Islet immunoisolation: experience with biopolymers
Q37263794Islet transplantation: the quest for an ideal source
Q36666407Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain
Q40933757Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion
Q32043185Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules--in vitro cryopreservation studies
Q29615286Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Q34284217Microencapsulation of islets within alginate/poly(ethylene glycol) gels cross-linked via Staudinger ligation
Q34779793Microfabrication technology for pancreatic cell encapsulation
Q30882242NMR properties of alginate microbeads
Q61196605Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes
Q45997189Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.
Q45180749New technologies for bioartificial organs
Q36154188Non-invasive evaluation of alginate/poly-l-lysine/alginate microcapsules by magnetic resonance microscopy
Q40472049Novel Delivery of Pancreatic Islet Cells to Treat Insulin-Dependent Diabetes Mellitus
Q40620336Pancreas and kidney/pancreas transplants: experimental medicine or real improvement?
Q37109821Polymer-coated cannulas for the reduction of backflow during intraparenchymal infusions.
Q53614227Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules.
Q38922330Self-assembled gold coating enhances X-ray imaging of alginate microcapsules
Q37896760Smart medication through combination of synthetic biology and cell microencapsulation
Q57348459Stimulus-Responsive Polyelectrolyte Particles: From Nanospheres to Macroscopic Beads
Q47243032Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. V. Determination of carbohydrate and protein permeation through microcapsules by reverse-size exclusion chromatography
Q86660871Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient
Q41569972Synthesis and Evaluation of a Sodium Alginate-4-Aminosalicylic Acid Based Microporous Hydrogel for Potential Viscosupplementation for Joint Injuries and Arthritis-Induced Conditions
Q50184746The effect of hypoxia on free and encapsulated adult porcine islets-an in vitro study
Q43597024The effects of alginate composition on encapsulated betaTC3 cells
Q43661577The isolation and function of porcine islets from market weight pigs
Q35196565The use of biomaterials in islet transplantation
Q77325493Tissue modifications
Q35057824Towards ready-to-use 3-D scaffolds for regenerative medicine: adhesion-based cryopreservation of human mesenchymal stem cells attached and spread within alginate-gelatin cryogel scaffolds
Q33965029Transplantation for the treatment of diabetes mellitus
Q38630043Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus
Q73850458Treatment of type I diabetes using encapsulated islets
Q51190616Versatile, cell and chip friendly method to gel alginate in microfluidic devices
Q71345175Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice

Search more.